Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Gilead, BMS Revise Formulation For Three-Drug Regimen In HIV

Aug. 11, 2005

By Jennifer Boggs

Gilead, BMS Revise Formulation For Three-Drug Regimen In HIV

Aug. 11, 2005

By Jennifer Boggs

AmpliMed Picks Up Third Cancer Drug From University Of Arizona

Aug. 10, 2005

By Jennifer Boggs

AmpliMed Picks Up Third Cancer Drug From University Of Arizona

Aug. 10, 2005

By Jennifer Boggs

Isis Extends Antisense Deal With Lilly, Adds Third Drug

Aug. 9, 2005

By Jennifer Boggs

Isis Extends Antisense Deal With Lilly, Adds Third Drug

Aug. 9, 2005

By Jennifer Boggs

Advanced Life Sciences Gets $32M In Lethargic IPO Market

Aug. 8, 2005

By Jennifer Boggs

Advanced Life Sciences Gets $32M In Lethargic IPO Market

Aug. 8, 2005

By Jennifer Boggs

Par Dropping Advancis Deal After Amoxicillin Pulsys Miss

Aug. 5, 2005

By Jennifer Boggs

Par Dropping Advancis Deal After Amoxicillin Pulsys Miss

Aug. 5, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...